149 related articles for article (PubMed ID: 33564083)
1. ALOX12 mutation in a family with dominantly inherited bleeding diathesis.
Mitsui T; Makino S; Tamiya G; Sato H; Kawakami Y; Takahashi Y; Meguro T; Izumino H; Sudo Y; Norota I; Ishii K; Hayasaka K
J Hum Genet; 2021 Aug; 66(8):753-759. PubMed ID: 33564083
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
Nakano T; Hanasaki K; Arita H
J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164
[TBL] [Abstract][Full Text] [Related]
6. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
7. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
10. Impaired signal transduction in neonatal platelets.
Israels SJ; Cheang T; Roberston C; McMillan-Ward EM; McNicol A
Pediatr Res; 1999 May; 45(5 Pt 1):687-91. PubMed ID: 10231866
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
[TBL] [Abstract][Full Text] [Related]
12. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
14. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
15. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
Knezevic I; Dieter JP; Le Breton GC
J Pharmacol Exp Ther; 1992 Mar; 260(3):947-55. PubMed ID: 1545407
[TBL] [Abstract][Full Text] [Related]
20. Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency.
Faioni EM; Razzari C; Zulueta A; Femia EA; Fenu L; Trinchera M; Podda GM; Pugliano M; Marongiu F; Cattaneo M
Thromb Haemost; 2014 Dec; 112(6):1182-9. PubMed ID: 25102815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
